Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

COVID-19 And FDA: Official Tells How Pandemic Has Affected Agency’s Regulatory Work

Dec 18 2020

• By Elizabeth Orr

FDABldg1ExteriorWithCircle_1200x675

Related Content

Shuren Gives Peek Behind Curtain With 3 Lessons FDA’s Device Center Learned During Pandemic

Sep 21 2020

Unpacking The $2.2Tn Stimulus Act: Boosts To Medtech And Diagnostics To Fight Coronavirus

Mar 27 2020

On-Site Inspections Of US Device Makers Plummet 93% As FDA Scrambles For Virtual Solutions

Dec 01 2020

Coronavirus Crisis Highlights FDA’s Device Supply Chain Blind Spots

Feb 28 2020

Top CDRH Officials Tell EUA Holders: Don’t Procrastinate In Getting Products FDA-Approved

Oct 08 2020

CDRH’s Shuren Says Employee Burnout ‘Great Fear’ During Pandemic

Oct 09 2020

Facing Shortage, FDA Further Relaxes Face Mask, Face Shield And Respirator Guidance

Apr 03 2020

Additional Topics

United States Approvals Coronavirus COVID-19 FDA Policy Regulation Medical Device

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window